NewcelX Financial Statements From 2010 to 2025

NCEL Stock   2.63  0.10  3.95%   
NewcelX's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing NewcelX's valuation are provided below:
There are over one hundred nineteen available fundamental ratios for NewcelX, which can be analyzed over time and compared to other ratios. We recommend to check NewcelX's last-minute fundamental drivers against the all of the trends between 2010 and 2025.
Check NewcelX financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among NewcelX's main balance sheet or income statement drivers, such as Depreciation And Amortization of 3.2 K, Interest Expense of 240.9 K or Selling General Administrative of 1.9 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 1.07. NewcelX financial statements analysis is a perfect complement when working with NewcelX Valuation or Volatility modules.
  
Build AI portfolio with NewcelX Stock
Check out the analysis of NewcelX Correlation against competitors.
For more information on how to buy NewcelX Stock please use our How to buy in NewcelX Stock guide.

NewcelX Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets3.2 M2.2 M2.7 M
Pretty Stable
Short and Long Term Debt Total1.4 M1.5 M5.5 M
Slightly volatile
Other Current Liabilities176.2 K185.5 K619.1 K
Slightly volatile
Total Current Liabilities785.4 K826.8 K2.3 M
Slightly volatile
Accounts Payable489.7 K515.5 K1.4 M
Slightly volatile
Cash2.7 M1.7 M2.3 M
Pretty Stable
Non Current Assets Total7.2 K7.6 K100.6 K
Pretty Stable
Non Currrent Assets Other269283101.5 K
Pretty Stable
Cash And Short Term Investments2.7 M1.7 M2.3 M
Pretty Stable
Common Stock Shares Outstanding146.6 K154.3 K1.2 M
Very volatile
Liabilities And Stockholders Equity3.2 M2.2 M2.7 M
Pretty Stable
Other Current Assets261.7 K160.2 K136.5 K
Slightly volatile
Other Stockholder Equity41.1 M72.8 M25 M
Slightly volatile
Total Liabilities785.4 K826.8 K8.1 M
Slightly volatile
Total Current AssetsM2.2 M2.6 M
Pretty Stable
Common Stock158 K166.4 K220.1 K
Slightly volatile
Net Receivables420 K400 K86.2 K
Slightly volatile
Short Term Debt1.3 M1.9 M1.1 M
Slightly volatile
Property Plant And Equipment Net12.3 K7.3 K24.9 K
Slightly volatile
Capital Lease Obligations1.6 M1.2 M1.7 M
Very volatile
Property Plant And Equipment Gross12.3 M13 M5.5 M
Slightly volatile
Short and Long Term Debt29.6 M28.2 M7.6 M
Slightly volatile
Capital Stock4.2 M4.8 M3.6 M
Slightly volatile
Non Current Liabilities Other2.9 M3.3 M3.6 M
Slightly volatile

NewcelX Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization3.2 K3.3 K3.1 M
Slightly volatile
Interest Expense240.9 K150 K555.2 K
Slightly volatile
Selling General Administrative1.9 M3.2 M1.6 M
Pretty Stable
Other Operating Expenses7.7 M4.4 M6.5 M
Slightly volatile
Research Development400.9 K422.1 K3.6 M
Pretty Stable
Total Operating Expenses7.7 M4.4 M6.5 M
Slightly volatile
Selling And Marketing Expenses77.8 K81.9 K2.5 M
Pretty Stable
Cost Of Revenue3.2 K3.3 K9.4 K
Slightly volatile
Reconciled Depreciation1.5 M1.5 M1.8 M
Pretty Stable

NewcelX Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation140.9 K125.6 K110.2 K
Slightly volatile
Begin Period Cash Flow852.8 K897.7 K1.6 M
Slightly volatile
Total Cash From Financing Activities7.2 MM6.7 M
Very volatile
End Period Cash Flow2.7 M1.7 M2.3 M
Pretty Stable
Depreciation3.2 K3.3 K9.6 M
Pretty Stable

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Average Payables1.6 M1.8 M1.4 M
Slightly volatile
Capex To Depreciation1.411.17950.4079
Slightly volatile
Payables Turnover0.00540.00640.0055
Slightly volatile
Cash Per Share21.0122.116830.2615
Very volatile
Days Payables Outstanding68.8 K56.7 K69.2 K
Slightly volatile
Income Quality2.262.15460.9157
Slightly volatile
Current Ratio2.832.69191.8387
Pretty Stable
Capex Per Share0.05460.0520.0083
Slightly volatile
Average Receivables33.8 K23.4 K26.6 K
Slightly volatile
Interest Debt Per Share1.891.992327.7 K
Very volatile
Debt To Assets0.971.025.4551
Very volatile
Days Of Payables Outstanding68.8 K56.7 K69.2 K
Slightly volatile
Ebt Per Ebit0.430.45221.0785
Slightly volatile
Effective Tax Rate7.0E-48.0E-49.0E-4
Slightly volatile
Quick Ratio2.832.69191.8413
Pretty Stable
Cash Ratio2.122.01441.6801
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.11.151.0177
Slightly volatile
Debt Ratio0.971.025.4551
Very volatile

NewcelX Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap718.3 M808.1 M881.1 M
Slightly volatile
Enterprise Value718.9 M808.8 M881.8 M
Slightly volatile

NewcelX Fundamental Market Drivers

About NewcelX Financial Statements

NewcelX investors utilize fundamental indicators, such as revenue or net income, to predict how NewcelX Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Cost Of Revenue3.3 K3.2 K

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Prophet
When determining whether NewcelX is a strong investment it is important to analyze NewcelX's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact NewcelX's future performance. For an informed investment choice regarding NewcelX Stock, refer to the following important reports:
Check out the analysis of NewcelX Correlation against competitors.
For more information on how to buy NewcelX Stock please use our How to buy in NewcelX Stock guide.
You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of NewcelX. If investors know NewcelX will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about NewcelX listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of NewcelX is measured differently than its book value, which is the value of NewcelX that is recorded on the company's balance sheet. Investors also form their own opinion of NewcelX's value that differs from its market value or its book value, called intrinsic value, which is NewcelX's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because NewcelX's market value can be influenced by many factors that don't directly affect NewcelX's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between NewcelX's value and its price as these two are different measures arrived at by different means. Investors typically determine if NewcelX is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, NewcelX's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.